IDXXIDEXX Laboratories, Inc.

$47B

Q1 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$576M+7.1% YoY

Gross Profit

$332M57.6% margin

Operating Income

$133M23.1% margin

Net Income

$103M17.8% margin

EPS (Diluted)

$1.17

QoQ Revenue Growth

+4.9%

Cash Flow

Operating Cash Flow

$34M

Free Cash Flow

-$4M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$1.6B

Stockholders' Equity

$52M

Cash & Equivalents

$117M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$576M	$538M	+7.1%
Gross Profit	$332M	$303M	+9.4%
Operating Income	$133M	$113M	+17.8%
Net Income	$103M	$89M	+14.8%

Revenue Segments

Up Front Customer Loyalty Programs And Volume Commitment Programs

$1.4B95%

Reagent Rental Programs

$38M3%

Extended Warranties And Post Contract Support

$27M2%

Instrument Rebate Programs

$5M0%

Geographic Segments

UNITED STATES

$358M79%

Asia Pacific

$60M13%

CANADA

$23M5%

Latin America

$13M3%

IDXX Q1 2019 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena